TP53 and gastric cancer: Mutations in tumor suppressor TP53, the most frequently mutated cancer-associated gene in gastric cancers, were significantly more frequent in the ELF3/HNF4A up-regulated group (67.3%) compared with the non-up-regulated group (28.6%, Fisher’s exact test p = 0.0003, Fig. 8).